For the Inventor, By the Inventor

Enter assignee name

Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.

USPTO Granted Patents = 36

% Expired Patents = 19.4

CIPO Patents = 1

EPO Patents = 14

Trademarks = 3

Forward Citations = 295

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Shunji Haruta (19 out of 22 patents)

Ryoichi Nagata (17 out of 17 patents)

Tatsuo Tsutsui (6 out of 15 patents)

4. Takefumi Gemba (4 out of 9 patents)

5. Hidetoshi Yamashita (2 out of 2 patents)

6. Nobuyuki Suzuki (2 out of 2 patents)

7. Takashi Hanafusa (2 out of 4 patents)

8. Toshikazu Oki (2 out of 61 patents)

9. Genji Satoyoshi (2 out of 2 patents)

10. Hideaki Mishima (2 out of 2 patents)

11. Yutaka Kawakami (1 out of 13 patents)

12. Yusuke Torikai (1 out of 1 patent)

13. Ikumi Shiga (1 out of 1 patent)

14. Masatoshi Kashima (1 out of 1 patent)

15. Hiroaki Magotani (1 out of 1 patent)

36 patents: Sort by Forward Citations

1. 12503841 - Urine scattering prevention device (2025-12-23),

2. 12478581 - Powder formulation for intranasal administration, and manufacturing method thereof (2025-11-25),

3. 12343472 - Powder preparation, cartridge, and device (2025-07-01),

4. 12246130 - Medicine dispensing device and method for manufacturing same (2025-03-11),

5. 12137706 - Micro-encapsulated aquaculture feed (2024-11-12),

6. 12102754 - Intranasal delivery devices (2024-10-01),

7. 11872314 - Pharmaceutical compositions (2024-01-16),

8. 11744967 - Intranasal delivery devices (2023-09-05),

9. 11559640 - Medicine storage cartridge with nozzle, sprayer therefor, and powdered medicine dispensing device for nasal cavity (2023-01-24),

10. 11311615 - Vaccine compositions (2022-04-26),

11. 10792253 - Pharmaceutical compositions (2020-10-06),

12. 10463723 - Methods and compositions for intranasal delivery (2019-11-05),

13. 10322173 - Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent (2019-06-18),

14. 10293123 - Test substance administration system for animal experiment (2019-05-21),

15. 10195139 - Preparation for transnasal application (2019-02-05),

Shin Nippon Biomedical Laboratories, Ltd. is a leading contract research organization (CRO) specializing in preclinical and early phase clinical studies. With over 30 years of experience, we offer a wide range of services to support pharmaceutical and biotechnology companies in drug development. Our state-of-the-art facilities, experienced scientists, and dedication to quality ensure reliable and timely results. We are committed to advancing medical research and improving human health through our innovative solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

36 Patents

#2 in Kagoshima

#2,097 in Japan

#18,680 in the World

Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.

Forward Citations = 295

20 inventors:

Shunji Haruta (19 out of 22 patents)

Ryoichi Nagata (17 out of 17 patents)

Tatsuo Tsutsui (6 out of 15 patents)

4. Takefumi Gemba (4 out of 9 patents)

5. Hidetoshi Yamashita (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…